A hormone already known for curbing appetite and supporting weight loss may have a surprising second job: protecting the liver from inflammation and scarring. Researchers at McMaster University found that GDF15 activates a previously unknown brain-to-liver pathway that triggers the release of glucocorticoids, helping calm immune activity in the liver.
Weight-loss hormone GDF15 may also protect the liver from inflammation
Researchers at McMaster University discovered that the hormone GDF15, known for weight loss, also protects the liver from inflammation and scarring by activating a brain-to-liver pathway. This finding highlights potential new therapeutic avenues for liver health. Understanding such biological mechanisms could have implications for public health in Iran, where liver diseases are prevalent.
👥 Key Players
📰 What Happened
Researchers at McMaster University found that the hormone GDF15, known for aiding weight loss, also protects the liver from inflammation by activating a brain-to-liver pathway. This discovery could lead to new therapeutic options for liver health.
- GDF15 triggers the release of glucocorticoids that help reduce immune activity in the liver.
- The findings suggest potential new treatments for liver inflammation and scarring.
💡 Why It Matters
📚 Background
GDF15 is a hormone associated with appetite regulation and weight loss, and its newfound role in liver health opens up avenues for research in metabolic diseases.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%